Sentence examples for increasing high density from inspiring English sources

One agent for increasing high density lipoprotein levels, torcetrapib, did significantly change mortality, but this was an increase.

For example, a systematic review of fibrates on high density lipoprotein cholesterol levels showed an overall increase of 2.6 mg/dL 88 compared with our findings of alcohol increasing high density lipoprotein cholesterol levels by 3.5-4 mg/dL.

Both types of drugs have an effect on lipid particles, but the main effect of statins is to reduce low density lipoprotein cholesterol whereas fibrates are more effective in lowering triglyceride concentrations and increasing high density lipoprotein cholesterol concentrations.

These include increasing high density lipoprotein cholesterol, decreasing markers of platelet activation, improving cardiac, renal and endothelial function, and reducing endothelial stress, lipoprotein oxidation and, ultimately, improving the signs and symptoms of atherosclerosis.

Conclusions Neither niacin, fibrates, nor CETP inhibitors, three highly effective agents for increasing high density lipoprotein levels, reduced all cause mortality, coronary heart disease mortality, myocardial infarction, or stroke in patients treated with statins.

10 Conversely, genetic variants associated with decreased high density lipoprotein cholesterol were not associated with increased risk of cardiovascular disease, 11 12 13 14 as would be expected from observational studies, 15 and randomised intervention trials have confirmed that increasing high density lipoprotein cholesterol does not decrease the risk of cardiovascular disease.

However, only the root bark and stem bark fractions significantly (p < 0.05) increased high density lipoprotein cholesterol (HDL-c) (Table 1).

AUC and AGUC significantly increased high density lipoprotein and uric acid, respectively, while dietary nucleosides did not affect cholesterol and triglyceride concentrations in serum samples.

However, telmisartan/pitavastatin combinations could not further improve lipid levels on the basis of pitavastain, though single telmisartan markedly decreased triglyceride (TG) and slightly increased high density lipoprotein cholesterol (HDL-C).

Atorvastatin treatment reduced significantly the fasting plasma concentrations of VLDL cholesterol, LDL cholesterol and VLDL triglycerides (median% change) by 29, 44 and 27%, respectively, and increased high density lipoprotein (HDL) cholesterol by 19%, compared with baseline.

Increased risk for myocardial infarction, stroke, and diabetes, increased high density lipoprotein cholesterol, increased systolic and diastolic blood pressure, and even suppressed immune function".